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Methods for Evaluating the Effects
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Human Sperm Production
by Andrew J. Wyrobek*
Sperm tests provide a direct and effective way of identifying chemical agents that induce
spermatogenic damage in man. Four human sperm tests are available: sperm count, motility,
morphology (seminal cytology) and the Y-body test. These sperm tests have numerous
advantages over other approaches for assessing spermatogenic damage, and they have already
been used to assess the effects of at least 85 different occupational, environmental, and
drug-related chemical exposures. When carefully controlled, seminal cytology appears to be
statistically more sensitive than the other human sperm tests and should be considered an
integral part of semen analysis when assessing induced spermatogenic damage.
Human sperm studies have complex requirements and, before sampling, careful consideration
should be given to exposure details, group size and makeup, as well as animal and human data
that indicate spermatogenic effects. Several study designs are possible and should include
questionnaires covering medical and reproductive histories as well as known confounding
factors. Animal sperm tests, such as the mouse morphology test, may be usedto identify thetoxic
components of a complex mixture. Animal tests may also help assess the chemical effects on
fertility and reproductive outcome in cases when human data are incomplete. Further efforts are
needed in these areas to develop improved human sperm tests sensitive to induced spermatogenic
damage, to develop improved animal models of induced spermatogenic damage, to understand
the relationships among sperm changes, fertility, and reproductive outcome, and to develop
sperm tests with express mutational end points.
Introduction
Studies with numerous chemical agents in a
variety of mammalian species have shown that
sperm anomalies can be used as indicators, and in
certaininstances, asdosimetersofchemicallyinduced
spermatogenic damage (1,2). Various other ap-
proaches have also been proposed to assess chemi-
cally induced spermatogenic dysfunction including
testicular biopsies (3), questionnaire surveys (4)
and blood levels ofgonadotrophins (5). Sperm tests
have the advantage that they are noninvasive,
generally less expensive, require smaller sample
sizes, and are sensitive to small changes (1,2,5).
A recent survey ofthe literature (2) showed that
sperm tests have been more widely used to assess
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the effects of chemical exposures in man than was
generally suspected; more than 100 papers involv-
ingsome 85 different chemical exposures have been
published. This paperbriefly describes themethods
and applications of the four most common human
sperm tests, compares their relative sensitivities
and suggests guidelines for undertaking a new
human sperm studyinmen exposed totoxic agents.
The paper also discusses the role ofanimal studies,
the implication of semen findings for reproductive
outcome, and future research needs in these areas.
Description of Human
Sperm Tests
Human semen tests have a long history in the
diagnosis ofinfertility (5). Thus, it is not surprising
that the early attempts to assess altered spermato-
genic functionin menexposed tochemicals involvedmeasuring changes in the sperm parameters com-
monly used in fertility diagnosis, such as sperm
density (counts), motility, and morphology (seminal
cytology). The following is a very brief description
of these methods.
Sperm count is usually reported as the number of
sperm per milliliter of ejaculate (or as the total
number of sperm ejaculated) as determined by
hemocytometer (6). The measurement is techni-
cally easy, and automated methods are also avail-
able. However, interpretation of results may be
confounded by a number offactors, such as variable
continence time before ejaculation and collection of
an incomplete ejaculate (7).
Sperm motility is the swimming ability of the
sperm and has been expressed in a large variety of
ways (6). Although motility may be one ofthe best
performance evaluations ofspermatogenic function
in relation to fertility, it is also very sensitive to
time and temperature after collection (8). Thus,
semen motility is very difficult to measure in a field
study, especially when samples are collected at
home. Considerable emphasis has been put on
automated and quantitative methods for assessing
sperm motility (9).
Sperm morphology (also referred to as seminal
cytology) is the visual assessment of the shapes of
ejaculated sperm. Although sperm-head shape is
usually emphasized, some assessments also incor-
porate midpiece and tail abnormalities. In general,
there has been little agreement in the definition of
normal shapes or in the categories of abnormal
shapes. This has resulted in much interlaboratory
and interscorer variability (10,11). However, stud-
ies ofMacLeod (12), David et al. (13), Eliasson (14),
andothershaveshownthatquantitativeapproaches
to the visual assessment ofmorphology can be used
with considerably success. These assessments are
usually made by using smears that are air-dried,
fixed and stained with a Papanicolaou method
(15). Sperm can be systematically assigned to
shape categories. In evaluating the effects of ex-
posure, slides of controls should be concurrently
analyzed with slides of exposed men in a blind-
study design. Normal ranges have been established
for several unexposed populations.
We have developed a human morphology test by
describing 10 classes of sperm-head shapes (16,17)
and classifying 500 sperm per individual. Through
the intermittent use of coded standard slides, we
have been able to assure constancy in the visual
scoring criteria for spermmorphology over aperiod
ofmany years. Ourexperience with this test shows
that visual scoring criteria can be very objective
(unpublished data). We have applied this method to
men occupationally exposed to carbaryl (17) and
anesthetic gases (16). The carbarylworkers showed
higher proportions ofsperm with shape abnormali-
tiesthancontrolsbutnodoseresponse wasobserved
and there was no difference in sperm counts. No
effects ofanesthetic gases on spermwere observed.
In another study, men exposed to cancerchemo-
therapeutic agents showed drug-related decreases
in sperm counts and increases in sperm-shape ab-
normalities (18).
TheY-bodytestscoresthefrequencyoffluorescent
spots in human sperm stained with quinacrine dye.
Based on studies in somatic cells, it is thought that
these spots represent Y chromosomes (19). The
Y-bodytest scores the frequency ofspermwith two
spots, which are thought to represent sperm with 2
Y chromosomes due to meiotic nondisjunction (20).
Unlike the other sperm tests (counts, motility, and
morphology), the Y-body test has no direct coun-
terpart in the mouse or other common laboratory
animals. The Y-chromosomal fluorescence after
quinacrine staining seems to be unique to man and
certain apes (21). However, it should be noted that
the field vole, Microtus oeconomus, has a unique
distribution ofheterochromatin, which allows visu-
alization ofthe X and Y chromosome in spermatids
and possibly testicular sperm (22). Studies with
several chemical agents suggest that this system
may be a useful animal model for studying the
induction of sex-chromosomal nondisjunction in
male germ cells.
For the analysis of Y-bodies in human sperm,
air-dried smears can be fixed, stained and sperm
scored under a fluorescent microscope (19,20). The
number of sperm scored depends on the statistical
precision required. Each sperm is scored as OY
(containing no fluorescent body, presumably sperm
with no Y chromosome), 1Y (those sperm presuma-
bly containing one Y chromosome) and 2Y (sperm
presumably containing two Y chromosomes). We
have developed the method so that we can repeat-
edly visualize approximately 50% ofthe sperm with
a single fluorescent body (unpublished data). The
Y-body test is very new, its relationship to chro-
mosomal aneuploidy uncertain and only a few pop-
ulations of exposed men have been analyzed (2).
Applications of Human
Sperm Tests
The above methods have been applied to assess
spermatogenic function in at least 85 different
groups of chemically exposed men (2). Tables 1-4
categorize these agents into occupational and envi-
ronmental chemicals (Table 1), experimental and
therapeutic drugs (Tables 2 and 3), and recreational
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drug use (Table 4). Details ofthe studies surveyed
to generate these tables and the decision criteria
used to classify each agent as one with adverse
effects, suggestive of adverse effects or with no
apparent adverse effects are published elsewhere
(2). Several agents (not listed in these tables) have
been reported to improve sperm quality in some
cases (2).
Relative Sensitivities of
the Human Semen Tests
Experience with agents like dibromochloropro-
pane (DBCP) suggests that severe spermatogenic
damage may occur at doses that show no other
apparent clinical signs of toxicity. Therefore, for
chemical exposures it seems unlikely that analysis
of somatic cells (i.e., lymphocyte) can serve as a
surrogate for effects on male germ cells.
The four human sperm tests described above are
technically straightforward methods. The tests for
counts, morphology, and Y-bodies are parameters
that do not appear to be readily affected by
postejaculation technical factors (2). Motility, how-
ever, is highly sensitive to time and temperature
factors. In studies where home collection is used
the motility test is not practical (8).
The statistical variations of the tests for counts,
morphology, and double Y-bodies were recently
Table 1. Effects of occupational and environmental chemicals on human sperm.'
Agents suggestive of Agents with no
Agents with adverse effects adverse effects apparent adverse effects
Carbon disulfide Carbaryl Anesthetic gases
Dibromochloropropane Kepone Epichlorohydrin
Dibromochloropropane + ethylene dibromide Glycerine production compounds
Lead Polybrominated biphenyls
Toluenediamine + dinitrotoluene
aTable entries arebased on studies ofsperm counts, motility, morphology and double Y-bodies. The assignment ofindividual agents
to columns is based on the data provided in the papers reviewed by the Human Sperm Reviewing Committee of the U.S.
Environmental Protection Agency (EPA) GENE-TOX Program (2). These entries are generally based on few studies and may be
expected to change as more data become available.
Table 2. Experimental and therapeutic drugs and agents or combinations of agents with adverse effects on human sperm.'
Acridinyl anisidide
Adriamycin
Aspartic acid
Clorambucil
Clorambucil + mechlorethaamine + azathioprine
Clomiphene citrate
Cyclophosphamide
Cyclophosphamide + colchicine
Cyclophosphamide + prednisone
Cyclophosphamide + prednisone + azathoprine
CVP (cyclophosphamide + vincristine + prednisone)
CVPP (cyclophosphamide + vincristine + procarbazine +
prednisone)
Cyproterone acetate
Danazol + methyl testosterone
Danazol + testosterone enanthate
Enovid
Gossypol
Leutineizing hormone releasing factor agonist
Medroxyprogesterone acetate
Medroxyprogesterone acetate + testosterone enanthate
Medroxyprogesterone acetate + testosterone propionate
Megestrol acetate + testosterone
Metanedienone
Methotrexate
MOPP (Mechlorethamine + vincristine + procarbazine +
prednisone)
MVPP (Mechlorethamine + vinblastine + prednisolone +
procarbazine)
Norethandrolone
Norethindrone
Norethindrone + norethandrolone + testosterone
Norgestrel + testosterone enanthate
Norgestrienone + testosterone
Prednisolone
Propafenon
R-2323 + testosterone
Sulphasalazine
Testosterone
Testosterone cyclopentylpropionate
Testosterone enanthate
Testosterone propionate
VACAM (Vincristine + adriamycin + cyclophosphamide +
actinomycin D + medroxyprogesterone acetate)
WIN 13099
WIN 13099 + diethylstilbestrol
WIN 17416
WIN 18446
aTable entries are based on studies ofsperm counts, motility, morphology and double Y-bodies. The assignment ofindividual agents
to columns is based on the data provided in the papers reviewed by the Human Sperm Reviewing Committee of the U.S.
Environmental Protection Agency (EPA) GENE-TOX Program (2). These entries are generally based on few studies and may be
expected to change as more data become available.
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Table 3. Effects ofother experimental and therapeutic drugs
on human sperm.'
Agents suggestive of Agents with no apparent
adverse effects adverse effects
Centrochroman Bromocriptine
Cimetidine Lysine
Colchicine Methyltestosterone
Diethylstilbestrol Niridazole
Methadone Norethindrone + testosterone
Metronidazole Orinthine
Nitrofurantoin Tryptophan
Norethandrolone +
testosterone WIN 59, 491
Trimeprimine
aTable entries are based on studies ofsperm counts, motility,
morphology and double Y-bodies. The assignment of individual
agents to columns is based on the data provided in the papers
reviewed by the Human Sperm Reviewing Committee of the
U.S. Environmental Protection Agency (EPA) GENE-TOX
Program (2). These entries are generally based on few studies
and may be expected to change as more data become available.
Table 4. Effects of recreational drug use on human sperm.
Agents with Agents suggestive Agents with no
adverse of adverse apparent adverse
effects effects effects
Alcoholic beverages Tobacco smoke None
(chronic alcoholism)
Marijuana
aTable entries are based on studies ofsperm counts, motility,
morphology and double Y-bodies. The assignment of individual
agents to columns is based on the data provided in the papers
reviewed by the Human Sperm Reviewing Committee of the
U.S. Environmental Protection Agency (EPA) GENE-TOX
Program (2). These entries are generally based on few studies
and may be expected to change as more data become available.
compared for a group of control men (17). Sperm
samples from approximately 25 men were required
in both the exposed and control groups to detect a
25% change in the mean proportion of abnormally
shaped sperm. Y-bodyanalysesand countsrequired
over 40 and 200 men, respectively, to detect a 25%
change in means. This comparison suggests that
the human sperm morphology test is statistically
more sensitive to small induced changes than the
other two tests. However, it is important to realize
that a chemical exposure may preferentially affect
any of these sperm parameters irrespective of its
statistical sensitivity. At present, data are still
insufficient to predict (a) which parameterwould be
mostsensitive toanagent or(b)theinterdependence
ofthe parameters. Therefore, the conservative ap-
proachforassessingchangesinhumanspermatogenic
function should include tests for sperm count, mor-
phology, Y-body, and, wheneverpractical, motility.
Guidelines for New Human
Sperm Studies
Laboratory analyses of sperm tests represent
only a small part ofa human sperm study. Depend-
ing on the exposure under consideration, these
studies typically require lengthy interactions with
unions, management, local and state government,
lawyers, physicians, hospital administrators, and
human subject committees before any donors are
contacted. The following criteria should be consid-
ered to determine if a human sperm study is
warranted:
(a) Are there animal dataavailable suggestinga
spermatogenic effect of the exposure under
consideration? (Animal datamay exist inthe
literature or may be obtained using the
short-term animal sperm tests.), or
(b) Are there human data that suggest that
there may be a problem with infertility or
pregnancy outcome that could be linked to
the exposed male?
Ifthe exposure under consideration meets these
criteria, the following additional data should be
obtained to aid in study design. (Though these
points are generally self-evident, they are included
because they have been often overlooked in human
sperm studies.)
(a) What are the demographics ofthe exposure
(size of the exposed population, geographic
location, etc.)? The size of the exposed
cohort is an important consideration since,
as described above, the number of men
sampled will be related to the statistical
sensitivity for each semen parameter. The
geographic dispersion ofthe exposed cohort
is an important cost factor as well as a
possible cause of sampling biases.
(b) Who was exposed (how many men, what are
their ages and religious backgrounds, etc.)?
Such factors can be expected to affect the
participation rates.
(c) What are the details ofthe exposure (route,
duration, dose, when it occurred in relation
to the proposed time of semen collection,
etc.)? It is well known from animal and some
human studies that the occurrence ofsperm
anomalies is related to exposure dose. In
addition, careful attention needs to be given
to the time since the last exposure; since the
effects of certain agents may be reversible,
false negative results may appearifthe time
is too long.
(d) Can the exposed population be divided into
dose groups? Every effort should be made
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to group the exposed cohort by dose esti-
mates, since adose-related effectisextremely
strong evidence for an identification of a
human testicular toxin.
A questionnaire approach to assessing human
problems in fertility and reproductive outcome
should also be considered. This approach may be
especially effective when large numbers of people
of child-bearing ages have been exposed and the
major exposures were many years ago. Human
sperm studies are likely to be effective when
smaller numbers of men are involved (see above
section) and the major exposures are suspected to
be recent or ongoing.
When considering sperm studies several study
designs are possible. Since between-male variabil-
ity in semen characteristics is high even among
fertile and presumably healthy men, rather large
numbers of cooperative subjects are required to
establish differences between control and exposed
groups in cross-sectional studies (each individual
sampled only once). Longitudinal study designs
may be more appropriate when fewer men are
availableforsampling. Inthisstudydesign, repeated
semen samples are collected from each man at
different times in relation to the time of exposure
and compared to assess chemically induced sperm
defects. Since variationofspermmorphologywithin
an individual is considerably less than variation
among individuals (23), in principle, fewer people
are required for induced changes to be detected.
These studies, however, have some constraints:
repeated samplings during a period of months and
perhaps years are required; samples before expo-
sure are needed (or within days of an acute expo-
sure before any induced effects on morphology are
seen); and the number of men needed for an
effective study is unknown.
The effects of age, smoking, illness, medication,
and other possibly confounding factors, especially
those involving heat exposure, must be considered
in the analysis of all human sperm data.
Possible Roles for Animal Tests
The availability ofboth animal and human sperm
tests suggests several applications of animal stud-
ies in the assessment ofchemically induced sperma-
totoxicity, antifertilityeffects, andheritablegenetic
abnormalities in man. First, animal sperm tests
(such as mouse morphology) may be used to screen
large numbers ofagents to establish a ranking that
sets priorities foridentifying exposed men. Second,
animal sperm studies may also be useful in evaluat-
ing an agent or the components of a complex
mixture that are suspected of affecting human
sperm (such as in an occupational or environmental
exposure). Third, animal breeding tests may be
used to study the relationship between changes in
sperm parameters, fertility changes, and heritable
consequences.
Since little is known ofthe quantitative relation-
ships between induced sperm abnormalities and
heritable genetic damage, indirect methods may be
needed to assess the genetic risk to offspring of
men who show induced sperm anomalies. By com-
bining data from short-term mutagen bioassays
(e.g., Salmonella/microsome assay, mammalian so-
maticcellmutationassays), whichmaydemonstrate
mutagenic potential, with data from animal and
human sperm tests, which may demonstrate activ-
ity in the testes, we may be able to evaluate
whether or not a mutagen is active in the testes.
Further studies are needed to investigate this
approach.
Genetic Implications of
Chemically Induced
Sperm Defects
Evidence from Human Studies
Although itis generally agreed that majorreduc-
tions in sperm counts and motility are linked to
reduced fertility, it remains unclear which sperm
parameter(s), if any, is predictive of reproductive
failure or heritable genetic abnormalities. Human
data on this question are very limited. Infertility is
seen in patients with 100% acrosomeless, round-
headedspermatozoa(24), suggestingthatsometypes
of sperm shape abnormalities are associated with
infertility. Human studies with DBCP showed the
strong link between reduction in sperm counts and
infertility (25). Regarding reproductive outcome,
Furuhjelm et al. (26) reported that a group of
fathersofspontaneousabortionsshowedsignificantly
higherspermabnormalities and lowerspermcounts
than fathers of normal pregnancies. This finding
suggests a possible link between poor semen qual-
ity and frequency of spontaneous abortions (27).
Clearly, morehumanstudies areneededtocompare
exposure ofthemaleparent, inducedspermdefects,
and reproductive outcome.
Evidence from Animal Studies
Mostofthestudiesongeneticvalidationofinduced
sperm defects have been conducted with sperm
morphology in mice. Several lines of evidence link
induction ofabnormally shaped spermandheritable
genetic abnormalities (1). First, it is clear that
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spermshapingandtheproductionofabnormalsperm
are polygenically controlled by autosomal as well as
sex-linked genes. Second, in several studies using
agents that induce sperm abnormalities, sperm
abnormalities were transmitted to the male off-
spring ofthe exposed mice. Third, a briefsurvey of
the literature suggests that the mouse sperm mor-
phology test may be an effective prescreen for the
more expensive tests of heritable germ cell muta-
tions, such as heritable specific locus, heritable
translocation, and dominant lethal tests in mice.
False-negative responses with the mouse sperm
morphology test for these tests seem to be very
rare or nonexistent. However, data are needed for
more chemicals before this relationship can be used
with confidence. Spindle poisons that may cause
nondisjunction in germ cells can also be identified
with the mouse morphology test. Further studies
(probably best done in mice) are needed to under-
stand the quantitative relationships among dosage
regime, appearance of abnormal sperm shapes in
the semen, time between exposure and conception,
fertility of the exposed male, frequency of gen-
etically abnormal offspring, and fertility of the ab-
normal offspring.
Future Research Needs
Sperm tests have shown considerable promise in
the assessment of spermatogenic damage induced
by occupational and environmental exposures. But
the available human tests are first-generational and
carry many biases from their original applications
in fertility diagnosis. More research is needed to
adapt these available sperm tests and to develop
the statistical criteria for the effective assessment
ofchemically induced spermatogenic damage. More
work is also needed to develop improved animal
models of human spermatogenic damage, to study
the relationship among changes in sperm parame-
ters, fertility, and reproductive outcome and to
develop new indicators of reproductive toxicity in
the male, especially indicators of heritable genetic
damage.
The author thanks Mr. J. Cherniak and Mrs. A. Riggs forhelp
in editing and typing this manuscript; also L. Gordon and G.
Watchmaker for their technical excellence.
This work was performed under the auspices of the U.S.
Department of Energy by the Lawrence Livermore National
Laboratory under contract numberW-7405-ENG-48, and by the
U.S. Environmental Protection Agency.
This document was prepared as an account ofwork sponsored
by an agency of the United States Government. Neither the
United States Government nor the University of California nor
anyoftheiremployees, makes anywarranty, express orimplied,
or assumes any legal liability or responsibility for the accuracy,
completeness, orusefulness ofanyinformation, apparatus, prod-
uct, or process disclosed, or represents that its use would not
infringe privately owned rights. Reference herein to any specific
commercial products, process, or service by trade name, trade-
mark, manufacturer, or otherwise, does not necessarily consti-
tute or imply its endorsement, recommendation, or favoring by
the United States Government or the University of California.
The views and opinions of authors expressed herein do not
necessarily state or reflect those of the United States Govern-
ment thereof, and shall not be used for advertising or product
endorsement purposes.
REFERENCES
1. Wyrobek, A. J., Gordon, L. A., Burkhart, J. G., Francis,
M. C., Kapp, R. W., Letz, G., Mailing, H. V., Topham, J.
C., and Whorton, M. D. An evaluation of the mouse sperm
morphology test and other sperm tests in nonhuman mam-
mals: U.S. EPA Gene-Tox Program Report. Mutat. Res., in
press.
2. Wyrobek, A. J., Gordon, L. A., Burkhart, J. G., Francis,
M. C., Kapp, R. W., Letz, G., Mailing, H. V., Topham, J.
C., and Whorton, M. D. An;evaluation of human sperm as
indicatorsofchemicallyinduced alterations ofspermatogenic
function: U.S. EPA Gene-Tox Program Report, Mutat.
Res., in press.
3. Whorton, M. D., Milby, T. H., Krauss, R., and Stubbs, H.
S. Testicular function in DBCP exposed workers. J. Occup.
Med. 21: 161-166 (1979).
4. Levine, R. J., Symons, M. J., Balogh, S. A., Milby, T. H.,
and Whorton, M. D. Amethod formonitoring the fertility of
workers 2. Validation ofthemethod amongworkers exposed
to dibromochloropropane. J. Occup. Med. 23: 183-188 (1981).
5. Eliasson, R. Clinical examination of infertile men. In:
Human Semen and Fertility Regulation in Men (E. S.
E. Hafez, Ed.), C. V. Mosby, St. Louis, 1976, pp.
321-331.
6. Freund, M., and Peterson, R. N. Semen evaluation and
fertility. In: Human Semen and Fertility Regulation in Men
(E. S. E. Hafez, Ed.), C. V. Mosby, St. Louis, 1976, pp.
344-354.
7. Schwartz, D., Laplanche, A., Jouannet, P., and David, G.
Within-subject variability of human semen in regard to
sperm count, volume, total number of spermatozoa, and
length of abstinence. J. Reprod. Fertil. 57: 391-395 (1979).
8. Makler, A., Zaidise, I., Paldi, E., and Brandes, J. M.
Factors affecting sperm motility. I. In vitro change in
motilitywithtimeafterejaculation. Fertil. Steril. 31: 147-154
(1979).
9. Mitchell, J. A., Nelson, L., and Hafez, E. S. E. Motility of
spermatozoa. In: Human Semen and Fertility Regulation in
Men (E. S. E. Hafez, Ed.), C. V. Mosby, St. Louis, 1976,
pp. 89-99.
10. Freund, M. Standards for the rating of human sperm mor-
phology. A cooperative study. Intern. J. Fertil. 11: 97-
180 (1966).
11. Fredricsson, B. Morphologic evaluation of spermatozoa in
different laboratories. Andrologia 11: 57 (1979).
12. MacLeod, J. Effects of environmental factors and of
antispermatogenic compounds on the human testis as
reflected in seminal cytology. In: Male Fertility and
Sterility: Proceedings, Serono Symposium (R. E. Mancini
and L. Martini, Eds.), Vol. 5, Academic Press, New
York, 1974, pp. 123-148.
13. David, G., Bisson, J. P., Czyglik, F., Jouannet, P., and
Gernigon, C. Anomalies morphologiques du spermatozoide
humain. 1) Propositions pour un systeme de classification.
J. Gyn. Obst. Bio. Repr. 4(Suppl. 1): 17-36 (1975).
14. Eliasson, R. Standards for investigation of human semen.
Andrologie 3: 49-64 (1970).EFFECTS OF ENVIRONMENTAL CHEMICALS ON HUMAN SPERM 59
15. Humason, G. L. In: Animal Tissue Techniques. W. H.
Freeman, San Francisco, 1972, pp. 456-457.
16. Wyrobek, A. J., Brodsky, J. B., Gordon, L., Moore, D. H.,
II, Watchmaker, G., and Cohen, E. N. Sperm studies in
anesthesiologists. Anesthesiology 55: 527-532 (1981).
17. Wyrobek, A. J., Watchmaker, G., Gordon, L., Wong, K.,
Moore, D., II, and Whorton, D. Sperm shape abnormalities
in carbaryl-exposed employees. Environ. Health Perspect.
40: 255-265 (1981).
18. Wyrobek, A. J., daCunha, M., Gordon, L., Watchmaker,
G., Gledhill, B., Mayall, B., Gamble, J., and Meistrich, M.
Sperm abnormalities in cancer patients. Proc. Am. Assoc.
Cancer Res. 21: 196 (1980).
19. Pearson, P. L., Bobrow, M., and Vosa, C. G. Technique for
identifying Y chromosomes in human interphase nucleus.
Nature 226: 78-80 (1970).
20. Kapp, R. W. Detection of aneuploidy in human sperm.
Environ. Health Perspect. 31: 27-31 (1979).
21. Seuanez, H. N. Chromosomes and spermatozoa of the
African great apes. J. Reprod. Fertil. (Suppl.) 28: 91-104
(1980).
22. Tates, A. D. Microtus oeconomus (Rodentia), a useful
mammal for studying the induction of sex-chromosome
nondisjunction and diploid gametes in male germ cells.
Environ. Health Perspect. 31: 151-159 (1979).
23. Sherins, R. J., Brightwell, D., and Sternthal, P. H. Longi-
tudinal analysis ofsemen offertile and infertile men. In: The
Testis in Normal and Infertile Men (P. Troen and H. R.
Nankin, Eds.), Raven Press, New York, 1977, pp. 473-488.
24. Nistal, M., Harruzo, A., and Sanchez-Corral, F. Tora-
tozoospermia absoluta de presentacion familiar. Experma-
tozoides microcefalos irregulares sin acrosoma. Andrologia
10: 234 (1978).
25. Whorton, D., Krauss, R. M., Marshall, S., and Milby, T. H.
Infertility in male pesticide workers. Lancet 2: 1259-1261
(1977).
26. Furuhjelm, M., Jonson, B., and Lagergren, C. G. The
quality of human semen in spontaneous abortion. Int. J.
Fertil. 7: 17-21 (1962).
27. Czeizel, E., Hancsok, M., and Viczian, M. Examination of
the semenofhusbandsofhabitually abortingwomen. Orvosi.
Hetilap. 108: 1591-1595 (1967).